Drugs Information: Dinutuximab
Basic Information
|
||
| ID | DDInter568 | |
| Drug Type | biotech | |
| Molecular Formula | C6422H9982N1722O2008S48 | |
| Molecular Weight | - | |
| Description | Dinutuximab is an immunotherapeutic agent used in combination with other immunomodulating agents to treat high-risk neuroblastoma in pediatric patients who achieve at least a partial response to prior first-line multiagent, multimodality therapy. | |
| ATC Classification | L01XC16 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Dinutuximab
| Severity level | ID | Name | Mechanism | Detail |
|---|